<313989F193FA967B88E397C396F28A7789EF944E89EF5F8FB4985E8F57315F914F95745F E696E6464>
|
|
|
- としなり すみい
- 7 years ago
- Views:
Transcription
1 1024 O1-001 O1-010 O2-001 O2-010 O3-001 O3-010 O4-001 O4-010 /TDM 1000 O5-001 O5-010 / O6-001 O6-010 //NST/ O7-001 O7-014 //// O8-001 O8-014 O9-001 O9-014 /// 1400 O O //DPC// 1025 O O O O / O O O O // O O /TDM/ O O ///NST O O /
2 F :00~11:00 O1-001 ICU/CCU O1-002 Linezolid O1-003 O1-004 O :01~12:01 O1-006 de-escalation O1-007 ICTde-escalationcarbapenem O1-008 O1-009 O F 4,5 10:00~11:00 O O O2-003
3 19 O2-004 O :01~12:01 O2-006 Capsaicinindomethacin O2-007 O2-008 O2-009 CCl4caspase-3, -8, -9 O2-010 RT-PCR1 PHA F 10:00~11:00 O3-001 O3-002 O3-003 Microsoft Access O O3-005 Cockcroft- GaultMDRD 11:01~12:01 O3-006 FEC75, FEC100
4 O3-007 O3-008 O3-009 HPLC LCMS O F /TDM 10:00~11:00 O O4-002 PKC O4-003 ph O4-004 O4-005 /TDM 11:01~12:01 O4-006 O O4-008 VCM24TDM O4-009 O4-010 VCM
5 F 1 / 10:00~11:00 O5-001 CYP O5-002 CYP2C9 PISCS O5-003 O5-004 O5-005 / 11:01~12:01 O5-006 O5-007 O5-008 O O5-010 per Pharmacy F //NST/ 10:00~11:00 O6-001 O6-002 O6-003 O6-004 HPLC
6 O //NST/ 11:01~12:01 O6-006 O6-007 O6-008 O6-009 O F 1-3 //// 14:00~15:24 O7-001 MRSA O7-002 C.difficile O7-003 MRSA O7-004 O7-005 O7-006 O7-007
7 19 //// 15:25~16:49 O7-008 O7-009 O7-010 CABG O7-011 K O7-012 O7-013 O F 14:00~15:24 O8-001 UGT1A1CPT-11 O8-002 Anthracycline rebamipide O8-003 TDM O8-004 O8-005 grade3 3 O O8-007 G-CSF
8 15:25~16:49 O8-008 O8-009 CPT-11 O O8-011 O8-012 Nedaplatin O8-013 Gefitinib Erlotinib O F /// 14:00~15:24 O9-001 HTML O9-002 O9-003 O9-004 O9-005 egfr O9-006 MAGE-3 O9-007 P-gp
9 19 /// 15:25~16:49 O9-008 O9-009 O9-010 O9-011 O9-012 O9-013 O F 1 //DPC// 14:00~15:24 O O O O O O O10-007
10 //DPC// 15:25~16:49 O Xa O ICU/CCU O DPC DPC data O HIV O O O F 9:15~10:39 O O O O O O O
11 19 10:40~12:04 O O O AD/HD O O O O F / 9:00~10:00 O O O /50M50133NPH O O / 10:01~11:01 O O O
12 O O / 11:02~11:50 O O O NaNa O F // 9:00~10:00 O M5E O O O O // 10:01~11:01 O13-006
13 19 O O O O // 11:02~12:02 O O O DS O O F 14:00~15:00 O QOL O Ca/Mg O weekly Paclitaxel/Carboplatin O O14-005
14 15:01~16:13 O O O weekly O O O F /TDM/ 14:00~15:00 O O in vitro O P-glycoprotein paclitaxel O O /TDM/ 15:01~16:13 O15-006
15 19 O O TDM1 TDM O TDM2 O TDM O Bilirubinirinotecan F 1 ///NST 14:00~15:00 O O O O O POS ///NST 15:01~16:13 O O O16-008
16 O O O F / 14:00~15:00 O O O O / 15:01~16:13 O O O OD30mg O % O DPC O O17-004
2
2 485 1300 1 6 17 18 3 18 18 3 17 () 6 1 2 3 4 1 18 11 27 10001200 705 2 18 12 27 10001230 705 3 19 2 5 10001140 302 5 () 6 280 2 7 ACCESS WEB 8 9 10 11 12 13 14 3 A B C D E 1 Data 13 12 Data 15 9 18 2
2011 2014 19 22-1 - - 2 - - 3 - - 4 - HIV HIV - 5 - SCU - 6 - ICUHCU NICU NICU HCU NICU ALSO - 7 - T-MRI FISH - 8 - ME NST - 9 - - 10 - da Vinci C C C DPC - 11 - C C C C C C - 12 - C C D D DPC D D - 13
Netcommunity SYSTEM X7000 IPコードレス電話機 取扱説明書
4 5 6 7 8 9 . 4 DS 0 4 5 4 4 4 5 5 6 7 8 9 0 4 5 6 7 8 9 4 5 6 4 0 4 4 4 4 5 6 7 8 9 40 4 4 4 4 44 45 4 6 7 5 46 47 4 5 6 48 49 50 5 4 5 4 5 6 5 5 6 4 54 4 5 6 7 55 5 6 4 56 4 5 6 57 4 5 6 7 58 4
.A. D.S
1999-1- .A. D.S 1996 2001 1999-2- -3- 1 p.16 17 18 19 2-4- 1-5- 1~2 1~2 2 5 1 34 2 10 3 2.6 2.85 3.05 2.9 2.9 3.16 4 7 9 9 17 9 25 10 3 10 8 10 17 10 18 10 22 11 29-6- 1 p.1-7- p.5-8- p.9 10 12 13-9- 2
地域と文化資産
11 2005 1980 151 20 65 1 6 37 7 A D E F G H - 2 - 2005 8 6 10:00 10:30 2-432 A D 7 E 8 1-F 1-G - 3 - 2005 H 1970 2005 8 26-4 - A B D E F G H 3 7 8 1 5 6 1 10-5 - 2005 10 1 5 6 1 1 30 2 3 5 3 2 1 2005 8
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 http://www.moj.go.jp/press/090130-1.html 55 56 57
, ,
41 42 73 121 121 10 122 11 122 12 131 13 131 15 10 133 16 11 133 17 12 136 18 13 141 19 14 141 20 15 146 21 16 149 22 17 149 23 174 18 24 73 19 241,301 25 20 242,301 (1) 26 21 331 27 22 241,341 28 23 242,341
01-3 目次 .xls
119 6 (170 ) 5 4 3 2 1 F F WC -1-2 -1-2 C C A P D 612 (1B) 613 (1B) 615 (1B) 616 (1B) 617 4B 611 B 610 B 608 B 607 B 606 B 605 B 603 B 602 B 601 (1B) 512 (1B) 513 (1B) 515 (1B) 516 (1B) 517 4B 518 (1B)
<313989F193FA967B88E397C396F28A7789EF944E89EF5F8FB4985E8F57315F914F95745F3039303931342E696E6464>
1024 P1-001 P1-568 1515 1600 1600 1645 1025 P2-001 P2-501 CJK-01 CJK-14 1130 1215 1345 1430 1130 1215 1345 1430 1024 1F P1-001 P1-002 P1-003 P1-004 P1-005 P1-006 1 P1-007 P1-008 P1-009 P1-010 P1-011 P1-012
J 9229-2887-26 P-A111 9229-2887-24 X-A110 9229-2887-24 
釧路市幼児教育振興計画（完成版）.doc
17 18 10 17 20 29 10 15 19 9,762 9,151 611 29 19 1,842 20 19 3,980 2,706 68 100 1,841 90 17 10 89 44 19 3,560 2,563 72 19 () () () 29 3,980 2,706 67.99 26 1,855 1,841 99.25 55 5,835 4,547 77.93 15
年計グラフ作成システム
2003/01/20 2.00 1/29 2003/01/20...2...3...4...5...7...9... 11...13...15...16...17...18...19...20...21...23...24...26...27 FAQ...29 2/29 2003/01/20 Microsoft Access 2000 Microsoft Excel 3/29 2003/01/20
2 / 43
Office 1 / 43 2 / 43 Access2003 3 / 43 Access2003 1 9 Access2003 4 / 43 5 / 43 6 / 43 7 / 43 8 / 43 9 / 43 10 / 43 11 / 43 12 / 43 13 / 43 14 / 43 15 / 43 16 / 43 17 / 43 18 / 43 19 / 43 20 / 43 21 / 43
障害者職域拡大カリキュラム研究会中間報告書構成案
3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16
untitled
PS3 10% 2-1 2-2 2-3 2 23 2-4 1 2 3 4 2-5 2.3.1 1 24 812 2-6 5 5% : (CVC) 5 2-7 CTZ 24 24 2-8 2.3.2 23 5HT3 12 2-9 2.3.3 12 12 23 710 13 5-FU 2-10 2.3.4 24 10 20 5-FU 2-11 2-12 (CTZ) 5HT3 H1 Achm (CTZ)
54 144 144 144 144 144 80 152 84 122 HTML
54 144 144 144 144 144 80 152 84 122 HTML P20 P24 P28 P40 P54 P84 P122 P138 P144 P152 P220 P234 P240 P242 1 1-1 1-2 1-3 1-4 1-5 1 1-6 1 2 2-1 2-2 A C D E F 2 G H I 2-3 2-4 C D E E A 2
- 1 -
- 1 - HIV cmc cmc - 2 - cmc() ( ) 5-3 - - 4 - (1) (2) (3) ( ) - 5 - 0537-73-2662 0537-35-2971 0548-63-1251 9 00 16 00-6 - - 7 - 2 3 4 5 6 1,328 1,848 2,368 2,888 3,408-8 - - 9 - - 10 - - 11 - 3-12 - (
...3 2...3 2.1 M10M19(1)(2) RL205...3 2.2 M21(1) RL205...5 2.3 M2RL205...11 2.4 M24 RL205...12 2.5 M25...12 2.6 M26...13 2.7 M27...15 2.8 M28...17 2.9
() 120130401 2013-04-01 1/22 2013-04-01 ...3 2...3 2.1 M10M19(1)(2) RL205...3 2.2 M21(1) RL205...5 2.3 M2RL205...11 2.4 M24 RL205...12 2.5 M25...12 2.6 M26...13 2.7 M27...15 2.8 M28...17 2.9 M29...18 2.10
untitled
16.4 35.6 44.6 49.3 49.3 51.8 60.5 69.0 81.0 78.2 78.7 77.9 82.9 88.4 88.5 98.7 26,931 25,31 11,03 16,256 10,32 6,872 60.36 40.80 62.26 11,189 10,62 12,56 11,46 6,985 60.95 12,87 7,919 61.53 12,44 7,657
橡サプリメント.PDF
Vol.13,No.1,2004 1 Feb.200Vol.13 No.1 Vol.13,No1,2004 2 70) ph H2 P450 P450 70) Vol.13,No.1,2004 ALDH N- H2 P-450 H2 ADH ADH ADH CYP ADH 200mg/dl ADH P-450CYP CYP CYP 17)18) N- 1 48g ADH 3 Vol.13,No1,2004
...1 (1)... 1 (2) ) )... 1 (3)... 1 (4) ) )... 2 (5)... 3 (6)... 3 (7) ) )... 4 (8)... 4 (9)... 4 (10) (1
...1 (1)... 1 (2)... 1 1)... 1 2)... 1 (3)... 1 (4)... 1 1)... 1 2)... 2 (5)... 3 (6)... 3 (7)... 4 1)... 4 2)... 4 (8)... 4 (9)... 4 (10)... 4...5 (1)... 5 1)... 5 2)... 5 (2)... 5 1)... 5 2)... 5 3)...
() CT X X Ver.5 64 ( 3.0 % / 24,, 25 H23 1 Dr 24 24 2 1 25 RI RI ICU 24 25 B 4500 13000 AHA-PALS 5 PALS 24 25 24 25 24 ICU 24 25 24 1 VA VA 25 25 VA HD VA 20 150 () () 25 2 24 25 24 24 414 102 25
IF_SUPRECUR_N29
! @ # $ % ^ & * ( ) _ + )# ! a s d a s d f g h a s d @ a s d a s # a s d f g h j $ a s d f g h a s d % a s a a s a s a s d f g ^ a s a s a s & a s d f a s d f g h a s d f g a s d f g a s d a s d * s
untitled
2000 2003 2004 DPC Continuum Care 32 IT HIPPA 18 IT MSW MSW MSW 18 HIPPAHealth Insurance Portability and Accountability Act of 1996 33 2002 34 1985 A B C 1020 D E F 35 A B IT A B DPC 36 RUG 19 19 RUGResource
KRAS KRAS
KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS : KRAS in vitro KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS
untitled
83 01 01 02 07 09 10 170,356 114,020 56,335 40,058 16,276 4,036 221 20,091 33 461 19,663 7,472 12,190 331 12,521 202,821 135,705 67,115 43,675 23,440 3,460 450 26,451 537 487 26,501 9,801 16,700 68
3 JAS JAS JAS 4
1 2 3 JAS JAS JAS 4 5 6 7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ph 102 106 K 31 32 13 3 15 79 33 34 35 36 37 20 6 H.22.3 http://www.caa.go.jp/foods/pdf/syokuhin19.pdf 38
1 2 3 4 5 6 7 9 14 10 10 27 11 12 LINE 13 3 14 15 16 17 ADHD 18 IQ 19 20 21 22 23 24 25 26 27 28 29 4 30 31 32 ADHD DVD 1 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 http://www.edu.city.kyoto.jp/seitoshido/
untitled
* * ** ** ** * ** -1- -2-16 10 23 65 17 17 30 83.1 54 1 2 3 1 4 1 80 20 91-3- 2 76 96 3-4- 12 11 10-5- -6- 1 2-7- 3 4 11-8- 67-9- LDADHD LD,2004 ADHD,2004,2004 1 10 2 11-10- 1 2-11- 17 3 4 2004 http://www.mext.go.jp/b_menu/houdou/16/01/04013002.htm
indd
Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf
museum data no74
74 Museum Data No.74 (2008.12) 1 2 Museum Data No.74 (2008.12) Museum Data No.74 (2008.12) 3 4 Museum Data No.74 (2008.12) Museum Data No.74 (2008.12) 5 6 Museum Data No.74 (2008.12) Museum Data No.74
14 Pocket Page Weekly 03 June 2016 No. 542 B
Pocket Page Weekly 03 June 2016 No. 542 B 13 14 Pocket Page Weekly 03 June 2016 No. 542 B Pocket Page Weekly 03 June 2016 No. 542 B 15 B 16 Pocket Page Weekly 03 June 2016 No. 542 Pocket Page Weekly 03
[] [] (1) () 1920 21 (2) () (3) () () () (4) () () () () 1 (1) () () (2) (3) (1) (2) () () () () () () () () () () SNS () () (3) () PR (4) () () () (1) () BSN NST () 25.9 45,428 11,778 (2) () () () (1)
MS Access ¤λȤ¤˽
MS Access 2003 : 2010 3 31 1 MS Office MS Access MS Access MS Word MS Excel MS PowerPoint MS Office Access Word Excel PowerPoint Access Access Word Excel MS Office ( ) Access Office 2003 Office 2007 Professional
IP S ( :H ) ( ) ( :H22 4
90 30 440 8515 4 101 0532 54 5111 0532 53 1379 IP 1. 2. 3. 11 1 1. 2. 12 0 1 2 3 8 0 8 0 8 S 5 5 0 5 2 1 13 0 5 0 4 (:H22 4 28 ) 1 1 0 5 () (:H22 4 28 ) 1 2 5 0 (: ) ー (: ) ー1 0 0 0 0 (: ) 1/26 50P7 21
600mg 600mg CTD 2 2.5 2.5 Page 3 2.5...7 2.5.1...7 2.5.2...27 2.5.3...28 2.5.4...42 2.5.5...55 2.5.6...79 2.5.7...97 2.5 Page 5 73 67 31 48 48A 102 104 105 106 ALP ALT(GPT) AST(GOT) AUC AUEC BID BUN
200mg 2005 3 876179 2002 3 3 200mg VFEND for Intravenous Use (1) (2) [4.1 ] (3) [4.2 ] (1) [1] (2) (3) [1] 3
DVIOUT
2003 02673006 1,.,,.,.,,. 2 SQL,.,,.,.,, SQL., Apriori[1]., [2].,.,.,. 3... ( 1)..,. SQL [3], [4]. 1: 4 ( ). 0.4%, 2.5%, MRSA, 17, 98. 2. 2: 5,. [1] R.Srikant, R.Agrawal, Mining Generalized Association
untitled
1 211022 2 11150 211022384 3 1000 23% 77% 10% 10% 5% 20% 15% 40% 5% 3% 8% 16% 15% 42% 5% 6% 4 =1000 = 66 5 =1000 = 59 6 52%(42% 1000 7 56% 41% 40% 97% 3% 11%, 2% 3%, 41 7% 49% 30%, 18%, 40%, 83% =1000
DPCはやわかり表紙_2014_H1-H4.indd
C O N T E N T S 1 2 3 4 5 6 7 A B AB 15 15 25 2SD 1 1 A B 15 AB 25 2SD 1 1 1 A B 25 2SD 10 10 10 AB 1 1 1 1 A 1 A 1 B1 15 B 2SD 8 9 10 11 12 13 14 15 16 17 18 DPCA DPCA 7 DPCA DPCA 7 DPCA DPCA 7 DPCA DPCA
1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025 50 10 1 2
0120-563-506 / 9001800 9001700 123113 0120-860-777 163-8626 6-13-1 Tel.03-6742-3111 http://www.himawari-life.co.jp 1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025
CONTENTS 8100 GDP
The Monthly NNA 20143 12 5? CONTENTS 8100 GDP CONTENTS DATA 12 10 POS 8100 Q9 1 10 Question 5 1 3 6 30 59 ASEAN 13 12 1 2 3 39.9% 38.4% 31.1% 28.8% 4.4% 4.7% China Thailand Indonesia Vietnam India 24 2
13 5 1 217.49 19.5 19.3 1 (10) (11) (4) 2 () 1 2 3 1 () 32 1 46 6 () 4 () (17) (74) 5 6 61 ー 7 () ( ) 8 9 10 11 12 27 31 5 13 829-1844 620-2654 669-6054 646-3054 681-6054 840-6054 856-6164 829-6124 844-7164
P01_表紙
INDEX MEDIA DATA 2017 2 MEDIA DATA 2017 3 4.9 6.1 3.4 3.9 11.7 11.4 11.5 10.9 7.7 4.9 5.7 6.5 4.4 3.9 2.4 3.3 MEDIA DATA 2017 4 70.6 69.2 67.3 63.7 11.6 8.9 10.4 6.9 16.6 15.6 15.1 12.7 9.7 8.6 9.0 14.2
(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................
28 B Pocket Page Weekly 10 January 2014 No. 417
28 B Pocket Page Weekly 10 January 2014 No. 417 30 B Pocket Page Weekly 10 January 2014 No. 417 32 B Pocket Page Weekly 10 January 2014 No. 417 圳 B 34 Pocket Page Weekly 10 January 2014 No. 417 B 36
- 2 -
Ver4.01-1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10-1 2 - 11 - - 12 - TU - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - Anderson 2 2 2 2 15 30 Anderson 1 1 mmh - 20 - 30 2 10 2 1 20 H H
PSCHG000.PS
FA X IT FA X c c c c cm RSA cprsp c http:w ww.pref.m iyazaki.jpfukushiipeindex.htm l, http:w ww.kenkomap.com m iyazaki Walking Sm oking GDP GDP e f e f e GDP f GDP IT GDP GDP GDP e f GDP GDP GDP
1.8.2 Page MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) / Candida glabrata (25) 0.25 / 0.5 Candida guilliermondii a) (2)
1.8.2 Page1 1.8.2 96% 2002 40 B 1 123 (1) in vitro 1) in vitro C. glabrata C. krusei 1 2 19951997 3 1999 2002 MIC MIC 2 1.8.2 Page2 1 19951997 MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) 0.016 /
16soukatsu_p1_40.ai
2 2016 DATA. 01 3 DATA. 02 4 DATA. 03 5 DATA. 04 6 DATA. 05 7 DATA. 06 8 DATA. 07 9 DATA. 08 DATA. 09 DATA. 10 DATA. 11 DATA. 12 DATA. 13 DATA. 14 10 11 12 13 COLUMN 1416 17 18 19 DATA. 15 20 DATA. 16
IT活用事例解説書
14 15 17 Information Technology ( ) 15 16 2 25 14 readme.txt index.html katsuyou.doc.doc.doc.doc.doc.doc.doc.doc.doc IT Access97 Access2000.xls.mdb.exe.mdb.exe IT.pdf 110 1114 1518 1922 2326 3952 2730
B 02 Pocket Page Weekly 13 March 2015 No. 478
INDEX B 02 Pocket Page Weekly 13 March 2015 No. 478 Exhibition B 04 Pocket Page Weekly 13 March 2015 No. 478 06 Pocket Page Weekly 13 March 2015 No. 478 B Pocket Page Weekly 13 March 2015 No. 478 B 07
untitled
........ ,..,..,..,,..,..,.. ,. , OECD ............ / :........................ :........ ... .. OECD OECD....... OECD Health Data ,, , :..... JR.... ,.. t-pa NICU ICU ICU.... NICU NICU NICU NICU.....
無印良品 キッチン・テーブル クリーニング・バス用品 2010春夏
200 6 6 7 8 2 4 6 6 7 7 7 2 8 8 9 9 9 20 20 2 22 22 22 24 24 24 25 26 26 28 28 29 29 30 30 3 www.muji.net 32 32 33 34 34 859275 35 39 4 42 35 36 35 37 36 38 39 40 40 40 4 4 42 44 43 45 46 47 47 48 49 50
無印良品 キッチン・テーブル・クリーニング・バス用品 2009 春夏
2009 2009 6 6 8 2 4 6 8 8 9 9 9 2 20 20 2 2 2 22 22 22 23 24 25 25 23 26 26 27 27 28 30 30 3 3 32 32 32 www.muji.net 34 34 35 35 35 36 36 37 37 37 38 39 854845 42 43 44 48 38 4 42 42 42 43 43 45 47 46
untitled
7 in 1 2 1 2 3 4 5 3 WellFare 1998 21 13 2 2005 3 2008 1 2 7 40 30 30 20 7 p1 1998 3 ( ) 5 14 14 14 MCA 110 100 4 4 5 9 3 2 4 60 60 60 3 2 5 1959 10 1983 3 4 1986 4 1992 4 2002 4 2004 4 2007 5 22 70 6
1...1 1...1 2...1 2.1...1 2.2...5 2.3...6 1...6 2...6 3...7 4...7 5...7 2.4...8 2...9 1...9 2... 10 2.1... 10 1... 10 2... 11 2.2... 12 1 2... 13 3... 18 4... 22 5... 23 6... 24 2.3... 34 1... 34 2...
橡Accessテキスト
Access95 9 6 9 13 1 -Access 1 1.1... 1 1.2... 2 2 95 3 2.1 95... 3 2.2... 5 2.3... 3 11 3.1... 11 3.2... 16 3.3... 17 4 20 4.1... 20 4.2... 21 5 22 5.1... 22 6-24 6.1... 24 6.2... 26 6.3... 27 6.4... 28
1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)
2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)
本文01id5.indd
1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906
untitled
... 2... 3... 5... 5... 8... 13... 18 HTML... 19 HTML... 20 PDF... 20 PDF... 22... 25 1 2 3 WEB (HTML,PDF, ) 4 5 6 7 WV O JDBC Data SourceDataSource01(N) > CSV 8 mysql JDBC mysql jar 9 10 11 12 13 14 15
16,,, 38, (1990) 17 J Toxicol Sci, 15 (Suppl IV), (1990) 18 Cognitive enhancers ( ), 13, (1990) ,, 120, (1991) 20,
1974 1,, 25, 1385-1391 (1974) 1983 2,, 34, 1451-1454 (1983) 1984 3,, Phencyclidine (PCP),, 4, 133-147 (1984) 1985 4,,,, 11, 132-146 (1985) 1986 5 Phencyclidine Angel Dust, 138, 178-180 (1986) 6, 6, 660-666
INFORMATION Key Woman 14 Pocket Page Weekly 01 July 2016 No. 546 B
Pocket Page Weekly 01 July 2016 No. 546 B 13 INFORMATION Key Woman 14 Pocket Page Weekly 01 July 2016 No. 546 B Pocket Page Weekly 01 July 2016 No. 546 B 15 B 16 Pocket Page Weekly 01 July 2016 No. 546